v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Company's Revenue

The following table summarizes the Company’s revenue for the years ended December 31, 2025 and 2024:

 

   Years ended December 31, 
   2025   2024 
Specimens - contracts with customers  $1,735,000   $9,104,950 
Shipping and other   193,998    186,165 
Revenue  $1,928,998   $9,291,115 
Schedule of Common Stock Issuable Upon Vesting and Exercise

The table below provides information on shares of the Company’s common stock issuable upon vesting and exercise, as of December 31:

 

   2025   2024 
Shares issuable upon vesting of RSUs   25    822 
Shares issuable upon exercise of stock options   2,901    8,460 
Shares issuable upon exercise of pre-funded warrants to purchase common stock   1,292,449     
Shares issuable upon exercise of Lender Warrant (defined below) to purchase common stock   625    625 
Shares issuable upon exercise of Underwriter Warrant (defined below) to purchase common stock   4,500    4,500